Inspira to Exhibit FDA-Cleared ART100 at AmSECT Conference March 25–29
Inspira Technologies will exhibit its FDA 510(k)-cleared INSPIRA ART100 at the AmSECT 64th International Conference in Austin, Texas from March 25–29, 2026 via its U.S. distributor Glo-Med Networks. The presentation signals a shift from development to sales execution as Inspira targets perfusionists and cardiac surgical teams for immediate clinical integration.
1. U.S. Showcase at AmSECT 2026
Inspira Technologies will present the ART100 system at the 64th AmSECT International Conference in Austin, Texas from March 25–29, 2026, using its distributor Glo-Med Networks to engage perfusionists and cardiac surgical teams who influence hospital purchasing decisions.
2. Leverages FDA 510(k) Clearance
The ART100 received FDA 510(k) clearance in May 2024, validating its readiness for cardiopulmonary bypass procedures in U.S. hospitals and supporting its positioning as a turnkey solution for perfusionists seeking integrated life-support and blood monitoring technology.
3. Active Distribution via Glo-Med Networks
By showcasing through Glo-Med, Inspira demonstrates an active commercial pipeline and a move into sales execution, aiming to convert FDA clearance into market share and expand its clinical partnerships and distribution footprint in the U.S.